Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Rev. cuba. enferm ; 37(2): e3746, 2021. tab
Artículo en Español | LILACS, BDENF, CUMED | ID: biblio-1347420

RESUMEN

Introducción: Uno de cada siete pacientes hospitalizados experimenta un evento adverso relacionado con la administración de medicación. Los errores de medicación son una de las causas más importantes de mortalidad y morbilidad prevenible. Objetivo: Evaluar la eficacia de una intervención formativa sobre la población de enfermeras de turno de noche de un hospital de agudos para mejorar el cumplimiento del protocolo de administración segura de medicación. Métodos: Ensayo experimental, pre-post intervención formativa, realizado en Hospital Clínic de Barcelona, durante 2015-2016. Población: 268 enfermeras en dos turnos de noche, muestra: 177 participantes (88 Grupo Control y 89 Grupo Experimental). La intervención consistió en sesiones informativas y acceso a Procedimiento escrito. El instrumento de medida fue el Procedimiento Normalizado de Trabajo de la institución mediante check-list de cumplimiento. Se realzó estudio uni-bivariable, mediante Chi2 y test de Fisher con significancia para p < 0,05. Resultados: Se realizaron 219 observaciones en Grupo Control y 207 en Grupo Experimental. De 17 variables analizadas, solo tres mostraron diferencias significativas: en Grupo Experimental mejoró el conocimiento del Procedimiento; se incrementó el uso del agua y jabón sobre la solución hidroalcohólica; y empeoró la identificación normalizada de fármacos pendientes de administrar. Ninguna de las 14 variables restantes mostró diferencias significativas. De 426 observaciones, solo se produjeron 3 errores de medicación en Grupo control, subsanados antes de su administración, y 0 en Grupo Experimental. Conclusiones: Las intervenciones formativas clásicas con receptores pasivos pueden no ser eficaces para mejorar la práctica enfermera en administración segura de medicación(AU)


Introduction: One in seven hospitalized patients experiences an adverse event related to administration of medication. Medication errors are one of the most important causes of preventable mortality and morbidity. Objective: To assess the efficacy of a training intervention with the population of night shift nurses in an acute care hospital, in order to improve compliance with the protocol for the safe administration of medication. Methods: Experimental trial, pre-post training intervention, carried out at Hospital Clínic of Barcelona, during 2015-2016. The population consisted of 268 nurses in two night shifts. The sample consisted of 177 participants (88 from the control group and 89 from the experimental group). The intervention consisted in information sessions and access to a written procedure. The measurement instrument was the Institution's Standard Work Procedure by means of a compliance check-list. Uni-bivariate study was performed, using chi-square and Fisher's test with a significance of P < 0.05. Results: 219 observations were carried out in the control group and 207, in the experimental group. Of seventeen variables analyzed, only three showed significant differences: in the experimental group, knowledge of the procedure improved, increase in the use of soap and water over hydroalcoholic solution, and worsening of standardized identification of drugs pending from being administered. None of the fourteen remaining variables showed significant differences. Of 426 observations, only three medication errors occurred in the control group, corrected before its administration, and zero occurred in the experimental group. Conclusions: Classic training interventions with passive receptors may not be effective to improve nursing practice in safe administration of medication(AU)


Asunto(s)
Humanos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/etiología , Educación en Enfermería/métodos , Horario de Trabajo por Turnos/efectos adversos , Errores de Medicación/efectos adversos , Preparaciones Farmacéuticas , Solución Hidroalcohólica
2.
Spectrochim Acta A Mol Biomol Spectrosc ; 223: 117360, 2019 Dec 05.
Artículo en Inglés | MEDLINE | ID: mdl-31319272

RESUMEN

We present the compositional analysis of three terrestrial analogues of Martian olivine-bearing rocks derived from both laboratory and flight-derived analytical instruments. In the first step, state-of-the-art spectroscopic (XRF, NIR and Raman) and diffractometric (XRD) laboratory systems were complementary used. Besides providing a detailed mineralogical and geochemical characterization of the samples, results comparison shed light on the advantages ensured by the combined use of Raman and NIR techniques, being these the spectroscopic instruments that will soon deploy (2021) on Mars as part of the ExoMars/ESA rover payload. In order to extrapolate valuable indicators of the mineralogical data that could derive from the ExoMars/Raman Laser Spectrometer (RLS), laboratory results were then compared with the molecular data gathered through the RLS ExoMars Simulator. Beside correctly identifying all major phases (feldspar, pyroxene and olivine), the RLS ExoMars Simulator confirmed the presence of additional minor compounds (i.e. hematite and apatite) that were not detected by complementary techniques. Furthermore, concerning the in-depth study of olivine grains, the RLS ExoMars simulator was able to effectively detect the shifting of the characteristic double peak around 820 and 850 cm-1, from which the FeMg content of the analyzed crystals can be extrapolated. Considering that olivine is one of the main mineral phases of the ExoMars landing site (Oxia Planum), this study suggests that the ExoMars/RLS system has the potential to provide detailed information about the elemental composition of olivine on Mars.

3.
Int J Antimicrob Agents ; 53(4): 520-524, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30471403

RESUMEN

BACKGROUND: Ceftazidime-avibactam has in vitro activity against Gram-negative bacilli that produce Class A, C and some D ß-lactamases, and has been successfully used in the treatment of infections caused by cephalosporin and carbapenem-resistant Enterobacteriaceae. However, actual experience in the treatment of OXA-48 carbapenemase-producing Enterobacteriaceae (CPE) is limited. OBJECTIVE: To review the characteristics and prognosis of OXA-48 CPE infections treated with ceftazidime-avibactam since introduction of the drug to the current centre during the period October 2014 to December 2016. METHODS: Retrospective assessment of episodes of infection caused by OXA-48 CPE treated with ceftazidime-avibactam, analysing data collected from infection diagnosis until 90 days after the end of treatment. RESULTS: Twenty-four episodes were analysed. Ceftazidime-avibactam was given as the initial definitive treatment in 15 (62.5%) and as salvage therapy in nine (37.5%). Intraabdominal (seven, 29%), urinary (six, 25%) and respiratory (five, 21%) were the most common sources. The 30-day and 90-day mortality rates were 8.3% and 20.8%, respectively. Clinical cure at 30 days was achieved in 62.5% of episodes. Four (16.7%) patients had adverse events, two of them were related to impaired renal function. Among patients who finished the treatment with ceftazidime-avibactam, seven (35%) were diagnosed with infection recurrence within 90 days of the end of treatment. CONCLUSIONS: From experience, ceftazidime-avibactam is an effective drug for treating infections due to OXA-48 CPE. From these results a better safety profile than the current best available therapy could be expected.


Asunto(s)
Antibacterianos/uso terapéutico , Compuestos de Azabiciclo/uso terapéutico , Enterobacteriaceae Resistentes a los Carbapenémicos/efectos de los fármacos , Ceftazidima/uso terapéutico , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Infecciones por Enterobacteriaceae/mortalidad , Inhibidores de beta-Lactamasas/uso terapéutico , beta-Lactamasas/metabolismo , Enterobacteriaceae Resistentes a los Carbapenémicos/aislamiento & purificación , Combinación de Medicamentos , Farmacorresistencia Bacteriana Múltiple , Infecciones por Enterobacteriaceae/microbiología , Femenino , Humanos , Klebsiella pneumoniae/efectos de los fármacos , Klebsiella pneumoniae/aislamiento & purificación , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Recurrencia , Estudios Retrospectivos , Terapia Recuperativa/métodos
4.
J Glob Antimicrob Resist ; 15: 136-139, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30036695

RESUMEN

OBJECTIVES: The steady progress in resistance of Pseudomonas aeruginosa (PA) has led to difficulties in treating infections due to multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. Ceftazidime/avibactam (CAZ/AVI) has in vitro activity against many of these strains, however clinical experience with CAZ/AVI is limited. This study aimed to evaluate the characteristics and outcomes of eight patients with infections due to MDR- or XDR-PA treated with CAZ/AVI, including four strains resistant to ceftolozane/tazobactam. METHODS: This was a retrospective descriptive study of patients admitted to a teaching hospital between January 2016 and May 2017 who received CAZ/AVI as initial or continuation therapy for infection due to MDR- and XDR-PA. RESULTS: The sources of infection were hospital-acquired lower respiratory tract infection in five patients (62.5%) and osteomyelitis, meningitis and catheter-related bacteraemia in one patient each. Clinical cure was achieved in 4 patients (50.0%). The 30-day and 90-day mortality rates were 12.5% and 37.5%, respectively. One patient (12.5%) developed encephalopathy that improved with discontinuation of the drug. CONCLUSIONS: CAZ/AVI may be a valuable option for serious infections due to resistant PA.


Asunto(s)
Antibacterianos/uso terapéutico , Compuestos de Azabiciclo/uso terapéutico , Ceftazidima/uso terapéutico , Farmacorresistencia Bacteriana Múltiple , Infecciones por Pseudomonas/tratamiento farmacológico , Pseudomonas aeruginosa/efectos de los fármacos , Anciano , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Estudios Retrospectivos , Centros de Atención Terciaria , Resultado del Tratamiento
5.
Biomed Res Int ; 2018: 9486258, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29682572

RESUMEN

To evaluate phenolic compounds and whether the combination of a tanniferous fruit and soybean oil could improve the performance, meat characteristics, and fatty acid (FA) profile in lambs, an experiment was conducted over 40 days with twenty creole male lambs (23.71 ± 3.46 kg). The lambs were allotted in a completely randomised design, with factorial arrangement 2 × 2, with the following dietary treatments: (1) control diet, (2) 2% Caesalpinia coriaria ground fruit dry matter (DM), (3) 2% soybean oil DM, and (4) 2% Caesalpinia coriaria fruit plus 2% soybean oil. The concentration of condensed tannins (CT) in Caesalpinia coriacea was 21.71 g/kg DM. No interactions were detected (P > 0.05) among soybean oil and Caesalpinia coriaria, and there were no differences in daily gain, intake, and feed conversion. Soybean oil reduced (P < 0.05) DM digestibility (68.05 versus 59.56%). In fat from the longissimus thoracis et lumborum (LTL) muscle, only linoleic acid presented differences (P < 0.05) between treatments. The combination of Caesalpinia coriacea fruit and soybean oil did not improve lamb performance at the included levels.


Asunto(s)
Caesalpinia/química , Frutas/química , Extractos Vegetales/farmacología , Ovinos/fisiología , Aceite de Soja/farmacología , Alimentación Animal , Animales , Dieta , Suplementos Dietéticos , Ácidos Grasos/metabolismo , Ácido Linoleico/metabolismo , Masculino , Carne , Ovinos/metabolismo
6.
Artículo en Inglés | MEDLINE | ID: mdl-27895014

RESUMEN

Ceftazidime-avibactam (CAZ-AVI) is a recently approved ß-lactam-ß-lactamase inhibitor combination with the potential to treat serious infections caused by carbapenem-resistant organisms. Few patients with such infections were included in the CAZ-AVI clinical trials, and clinical experience is lacking. We present a case series of patients with infections caused by carbapenem-resistant Enterobacteriaceae (CRE) or Pseudomonas aeruginosa (CRPa) who were treated with CAZ-AVI salvage therapy on a compassionate-use basis. Physicians who had prescribed CAZ-AVI completed a case report form. We used descriptive statistics to summarize patient characteristics and treatment outcomes. We used the Wilcoxon rank sum test and Fisher's exact test to compare patients by treatment outcome. The sample included 36 patients infected with CRE and two with CRPa. The most common infections were intra-abdominal. Physicians categorized 60.5% of patients as having life-threatening infections. All but two patients received other antibiotics before CAZ-AVI, for a median of 13 days. The median duration of CAZ-AVI treatment was 16 days. Twenty-five patients (65.8%) concurrently received other antibiotics to which their pathogen was nonresistant in vitro Twenty-eight patients (73.7%, 95% confidence interval [CI], 56.9 to 86.6%) experienced clinical and/or microbiological cure. Five patients (20.8%) with documented microbiological cure died, whereas 10 patients (71.4%) with no documented microbiological cure died (P = 0.01). In three-quarters of cases, CAZ-AVI (alone or combined with other antibiotics) cured infections caused by carbapenem-resistant organisms, 95% of which had failed previous therapy. Microbiological cure was associated with improved survival. CAZ-AVI shows promising clinical results for infections for which treatment options are limited.


Asunto(s)
Antibacterianos/uso terapéutico , Compuestos de Azabiciclo/uso terapéutico , Carbapenémicos/uso terapéutico , Ceftazidima/uso terapéutico , Anciano , Antibacterianos/farmacología , Compuestos de Azabiciclo/farmacología , Carbapenémicos/farmacología , Ceftazidima/farmacología , Combinación de Medicamentos , Enterobacteriaceae/efectos de los fármacos , Enterobacteriaceae/patogenicidad , Femenino , Humanos , Klebsiella oxytoca/efectos de los fármacos , Klebsiella oxytoca/patogenicidad , Klebsiella pneumoniae/efectos de los fármacos , Klebsiella pneumoniae/patogenicidad , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/patogenicidad , Terapia Recuperativa
7.
Rev. chil. cir ; 67(5): 506-510, oct. 2015. tab
Artículo en Español | LILACS | ID: lil-762623

RESUMEN

Objective: Evaluation of the effectiveness of autologous platelet rich plasma administered topically in the healing and prevention of complications of abdominoplasty after bariatric surgery. Material and Methods: The data from 30 patients who underwent abdominoplasty were analyzed: Group I: Rich plasma was administered autologous platelets in the surgery. Group II: Control. Study variables: complications (seroma, local infection and bleeding), length of stay and cost. Results: No significant differences were observed in the frequency of complications or length of stay. The use of platelet rich plasma raises the cost of the procedure. Conclusion: Even considering the limitations of the study because of its small sample size and lack of blinding, the results do not support the use of this complementary technique. Further studies are needed in the field of adhesives, sealants and local hemostatic.


Objetivo: Evaluación de la eficacia del plasma rico en plaquetas autólogo administrado de forma tópica en la cicatrización y prevención de las complicaciones de la abdominoplastía y dermolipectomía tras cirugía bariátrica. Material y Método: Serie de 30 pacientes afectos de faldón abdominal tras cirugía bariátrica, a los que se practicó dermolipectomía y abdominoplastía, divididos en dos grupos de 15 casos con aletorización simple. Grupo I: Se administró plasma rico en plaquetas autólogo en el lecho quirúrgico. Grupo II: Control. Variables de estudio: complicaciones (seroma, infección local y hemorragia), tiempo de estancia y coste. Resultados: No se aprecian diferencias significativas en la frecuencia de complicaciones ni en estancia media. El uso de plasma rico en plaquetas eleva el coste del procedimiento. Conclusión: Aun considerando las limitaciones del estudio por su corto número de casos y no cegamiento, los resultados no apoyan el uso de esta técnica complementaria. Estudios más avanzados son necesarios en el campo de los adhesivos, sellantes y hemostáticos locales.


Asunto(s)
Humanos , Masculino , Adulto , Femenino , Persona de Mediana Edad , Abdominoplastia/métodos , Complicaciones Posoperatorias/prevención & control , Plasma Rico en Plaquetas , Transfusión de Sangre Autóloga , Tiempo de Internación , Estudios Prospectivos
8.
J Antimicrob Chemother ; 70(11): 3004-13, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26260130

RESUMEN

OBJECTIVES: The main objective of this study was to investigate the relationship among the in vivo acquisition of antimicrobial resistance in Pseudomonas aeruginosa clinical isolates, the underlying molecular mechanisms and previous exposure to antipseudomonal agents. METHODS: PFGE was used to study the molecular relatedness of the strains. The MICs of ceftazidime, cefepime, piperacillin/tazobactam, imipenem, meropenem, ciprofloxacin and amikacin were determined. Outer membrane protein profiles were assessed to study OprD expression. RT-PCR was performed to analyse ampC, mexB, mexD, mexF and mexY expression. The presence of mutations was analysed through DNA sequencing. RESULTS: We collected 17 clonally related paired isolates [including first positive samples (A) and those with MICs increased ≥4-fold (B)]. Most B isolates with increased MICs of imipenem, meropenem and ceftazidime became resistant to these drugs. The most prevalent resistance mechanisms detected were OprD loss (65%), mexB overexpression (53%), ampC derepression (29%), quinolone target gene mutations (24%) and increased mexY expression (24%). Five (29%) B isolates developed multidrug resistance. Meropenem was the most frequently (71%) received treatment, explaining the high prevalence of oprD mutations and likely mexB overexpression. Previous exposure to ceftazidime showed a higher impact on selection of increased MICs than previous exposure to piperacillin/tazobactam. CONCLUSIONS: Stepwise acquisition of resistance has a critical impact on the resistance phenotypes of P. aeruginosa, leading to a complex scenario for finding effective antimicrobial regimens. In the clinical setting, meropenem seems to be the most frequent driver of multidrug resistance development, while piperacillin/tazobactam, in contrast to ceftazidime, seems to be the ß-lactam least associated with the selection of resistance mechanisms.


Asunto(s)
Antibacterianos/uso terapéutico , Farmacorresistencia Bacteriana , Evolución Molecular , Infecciones por Pseudomonas/tratamiento farmacológico , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/genética , Antibacterianos/farmacología , Proteínas de la Membrana Bacteriana Externa/genética , Electroforesis en Gel de Campo Pulsado , Perfilación de la Expresión Génica , Humanos , Unidades de Cuidados Intensivos , Pruebas de Sensibilidad Microbiana , Tipificación Molecular , Pseudomonas aeruginosa/clasificación , Reacción en Cadena en Tiempo Real de la Polimerasa , beta-Lactamasas/genética
9.
Antimicrob Agents Chemother ; 58(12): 7025-31, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25199780

RESUMEN

The role of linezolid in empirical therapy of suspected bacteremia remains unclear. The aim of this study was to evaluate the influence of empirical use of linezolid or glycopeptides in addition to other antibiotics on the 30-day mortality rates in patients with Gram-negative bacteremia. For this purpose, 1,126 patients with Gram-negative bacteremia in the Hospital Clinic of Barcelona from 2000 to 2012 were included in this study. In order to compare the mortality rates between patients who received linezolid or glycopeptides, the propensity scores on baseline variables were used to balance the treatment groups, and both propensity score matching and propensity-adjusted logistic regression were used to compare the 30-day mortality rates between the groups. The overall 30-day mortality rate was 16.0% during the study period. Sixty-eight patients received empirical treatment with linezolid, and 1,058 received glycopeptides. The propensity score matching included 64 patients in each treatment group. After matching, the mortality rates were 14.1% (9/64) in patients who received glycopeptides and 21.9% (14/64) in those who received linezolid, and a nonsignificant association between empirical linezolid treatment and mortality rate (odds ratio [OR], 1.63; 95% confidence interval [CI], 0.69 to 3.82; P = 0.275, McNemar's test) was found. This association remained nonsignificant when variables that remained unbalanced after matching were included in a conditional logistic regression model. Further, the stratified propensity score analysis did not show any significant relationship between empirical linezolid treatment and the mortality rate after adjustment by propensity score quintiles or other variables potentially associated with mortality. In conclusion, the propensity score analysis showed that empirical treatment with linezolid compared with that with glycopeptides was not associated with 30-day mortality rates in patients with Gram-negative bacteremia.


Asunto(s)
Acetamidas/uso terapéutico , Antibacterianos/uso terapéutico , Bacteriemia/tratamiento farmacológico , Bacterias Gramnegativas/efectos de los fármacos , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Oxazolidinonas/uso terapéutico , Anciano , Bacteriemia/microbiología , Bacteriemia/mortalidad , Bacteriemia/patología , Investigación Empírica , Femenino , Glicopéptidos/uso terapéutico , Bacterias Gramnegativas/crecimiento & desarrollo , Infecciones por Bacterias Gramnegativas/microbiología , Infecciones por Bacterias Gramnegativas/mortalidad , Infecciones por Bacterias Gramnegativas/patología , Humanos , Linezolid , Modelos Logísticos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Oportunidad Relativa , Puntaje de Propensión , Análisis de Supervivencia
10.
Proc Natl Acad Sci U S A ; 111(25): E2616-21, 2014 Jun 24.
Artículo en Inglés | MEDLINE | ID: mdl-24927584

RESUMEN

Despite a long-standing interest in the genetic basis of morphological diversity, the molecular mechanisms that give rise to developmental variation are incompletely understood. Here, we use comparative transcriptomics coupled with the construction of gene coexpression networks to predict a gene regulatory network (GRN) for leaf development in tomato and two related wild species with strikingly different leaf morphologies. The core network in the leaf developmental GRN contains regulators of leaf morphology that function in global cell proliferation with peripheral gene network modules (GNMs). The BLADE-ON-PETIOLE (BOP) transcription factor in one GNM controls the core network by altering effective concentration of the KNOTTED-like HOMEOBOX gene product. Comparative network analysis and experimental perturbations of BOP levels suggest that variation in BOP expression could explain the diversity in leaf complexity among these species through dynamic rewiring of interactions in the GRN. The peripheral location of the BOP-containing GNM in the leaf developmental GRN and the phenotypic mimics of evolutionary diversity caused by alteration in BOP levels identify a key role for this GNM in canalizing the leaf morphospace by modifying the maturation schedule of leaves to create morphological diversity.


Asunto(s)
Redes Reguladoras de Genes/fisiología , Hojas de la Planta , Proteínas de Plantas , Solanum , Factores de Transcripción , Transcriptoma/fisiología , Hojas de la Planta/anatomía & histología , Hojas de la Planta/genética , Hojas de la Planta/metabolismo , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Solanum/anatomía & histología , Solanum/genética , Solanum/metabolismo , Especificidad de la Especie , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
12.
Obes Surg ; 21(9): 1389-94, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21229331

RESUMEN

BACKGROUND: This study seeks to assess the effect of inspiratory muscle training (IMT) on pulmonary function, respiratory muscle strength, and endurance in morbidly obese patients submitted to bariatric surgery. METHODS: Thirty patients were randomly assigned to sham muscular training, or to IMT with a threshold device (40% of maximum inspiratory pressure, MIP), for 30 min/day, from the 2nd until 30th postoperative (PO) day. All of them were submitted to a standard respiratory kinesiotherapy and early deambulation protocol. Data on spirometry, maximum static respiratory pressures, and respiratory muscle endurance were collected on the PO days 2, 7, 14, and 30 in a blinded matter. RESULTS: IMT enabled increases in PO MIP and endurance, and an earlier recovery of the spirometry parameters FEV(1), PEF, and FEF(25-75%). Comparing to preoperative values, MIP was increased by 13% at the 30th PO day in the trained group, whereas control group had a reduction of 8%, with higher values for the IMT group (30th PO, IMT-130.6 ± 22.9 cmH(2)O; controls-112.9 ± 25.1 cmH(2)O; p < 0.05). Muscular endurance at the 30th PO day was increased in the trained group comparing to preoperative value (61.5 ± 39.6 s vs 114.9 ± 55.2 s; p < 0.05), a finding not observed in the control group (81.7 ± 44.3 vs 95.2 ± 42.0 s). CONCLUSIONS: IMT improves inspiratory muscle strength and endurance and accounts for an earlier recovery of pulmonary airflows in morbidly obese patients submitted to bariatric surgery.


Asunto(s)
Ejercicios Respiratorios , Derivación Gástrica , Gastroplastia , Enfermedades Pulmonares/prevención & control , Obesidad Mórbida/cirugía , Complicaciones Posoperatorias/prevención & control , Recuperación de la Función , Adulto , Femenino , Humanos , Enfermedades Pulmonares/etiología , Masculino , Persona de Mediana Edad , Obesidad Mórbida/fisiopatología , Resistencia Física , Ventilación Pulmonar , Espirometría
13.
Prim Care Diabetes ; 4(3): 145-53, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20478753

RESUMEN

UNLABELLED: The prevalence of diabetes in Mexico among those 20-64 years of age has increased from 7.2% in 1993 to 10.7% in 2000. National population-based surveys in Mexico demonstrated that 50% of the total population with diabetes had blood glucose levels of 200mg/dl or higher. Thus, diabetes care has become one of the most important public health challenges in this country. The aim of the study was to improve the quality of diabetes care in primary health care centers using the chronic care model and the breakthrough series (BTS) collaborative methodology. METHODS: Ten public health centers in the cities of Xalapa and Veracruz were randomly selected to participate in the project. Five of the health centers were randomly assigned to receive the intervention (intervention group) and the other five followed usual care (usual care group). The intervention was evaluated by A1c test before and after the intervention in both groups of patients. Patients were followed for 18 months from November 2002 to May 2004. Results were adjusted for the clustering of patients within practices and baseline measure. RESULTS: The proportion of people with good glycemic control (A1c<7%) among those in the intervention group increased from 28% before the intervention to 39% after the intervention. The proportion of patients achieving three or more quality improvement goals increased from 16.6% to 69.7% (p<0.001) among the intervention group while the usual care group experienced a non-significant decrease from 12.4% to 5.9% (p=0.118). The focus on the primary care team and the participation of people with diabetes were strategic elements incorporated into the methodology, expected to ensure sustainability of continued improvement of health outcomes. CONCLUSIONS: The intervention introduced modifications to solve problems identified by health teams in their practice and improved process and outcome measures of quality diabetes care. Most of the actions were directed at four components of the chronic care model: self-management support, decision support, delivery system design, and clinical information systems.


Asunto(s)
Conducta Cooperativa , Prestación Integrada de Atención de Salud/organización & administración , Diabetes Mellitus/terapia , Evaluación de Procesos y Resultados en Atención de Salud/organización & administración , Grupo de Atención al Paciente/organización & administración , Atención Primaria de Salud/organización & administración , Calidad de la Atención de Salud/organización & administración , Adulto , Actitud del Personal de Salud , Biomarcadores/sangre , Manejo de Caso/organización & administración , Diabetes Mellitus/sangre , Femenino , Hemoglobina Glucada/metabolismo , Adhesión a Directriz , Conocimientos, Actitudes y Práctica en Salud , Humanos , Hipoglucemiantes/uso terapéutico , Masculino , México , Persona de Mediana Edad , Programas Nacionales de Salud/organización & administración , Objetivos Organizacionales , Educación del Paciente como Asunto , Guías de Práctica Clínica como Asunto , Evaluación de Programas y Proyectos de Salud , Derivación y Consulta/organización & administración , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
14.
Am J Infect Control ; 37(9): 753-8, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19487049

RESUMEN

BACKGROUND: Pseudomonas aeruginosa cross-resistance to ceftazidime, imipenem, meropenem, piperacillin, and fluoroquinoles has been shown in experimental studies, but information regarding its impact in the clinical setting is scarce and inconsistent. The aim of this study was to assess whether previous exposure to ciprofloxacin influences on the sensitivity of those antibiotics in subsequent P aeruginosa bacteremic isolates. METHODS: Patients with P aeruginosa bacteremia were recorded from a blood culture surveillance program (1997-2007). Demographic characteristics, underlying diseases, setting of the infection, source of infection, previous antibiotic exposure, and antibiotic sensitivity were analyzed. RESULTS: We studied 572 cases of P aeruginosa bacteremia. There were 327 men (57.2%), and the mean age was 61.2 +/- 18 years. The bacteremia was nosocomial in 62.4% of episodes. Resistance rates of P aeruginosa isolates were 15.5% for ceftazidime, 16.7% for imipenem, 11.2% for meropenem, 12.3% for piperacillin-tazobactam, and 23.1% for ciprofloxacin. Exposure to ciprofloxacin during the previous 30 days was an independent predictor of resistance to ceftazidime (odds ratio [OR], 3; 95% confidence interval [CI]: 1.7-5.3; P < .001), imipenem (OR, 2; 95% CI: 1.1-3.7; P = .02), meropenem (OR, 2.7; 95% CI: 1.4-5.3; P = .004), piperacillin-tazobactam (OR, 2.4; 95% CI: 1.3-4.7; P = .007), ciprofloxacin (OR, 2.9; 95% CI: 1.7-4.9; P < .001), and multidrug resistance (OR, 2.5; 95% CI: 1.2-5.2; P = .02). CONCLUSION: P aeruginosa bacteremic isolates from patients who have been exposed to ciprofloxacin during the 30 days prior to the development of bacteremia have an increased risk of being resistant to ceftazidime, imipenem, meropenem, piperacillin-tazobactam, or ciprofloxacin and to have multidrug resistance.


Asunto(s)
Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Bacteriemia/microbiología , Ciprofloxacina/uso terapéutico , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/efectos de los fármacos , Resistencia betalactámica , beta-Lactamas/farmacología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Adulto Joven
15.
Artículo en Inglés | MEDLINE | ID: mdl-19436683

RESUMEN

This study aimed to investigate the effects of weekly singing classes on pulmonary function parameters and quality of life (QoL) of COPD patients. Forty-three patients were randomized to weekly classes of singing practice, or handcraft work. They performed spirometry and completed maximal respiratory pressure measurements, evaluations of dyspnea, and the Saint George's Respiratory Questionnaire, before and after 24 training classes. A functional evaluation, immediately after 10 minutes of singing practice, was also performed at the end of the study. Fifteen subjects completed the study in each group. In comparison to controls the singing group exhibited transitory elevations on the dyspnea Borg scale (p = 0.02), and inspiratory capacity (p = 0.01), and decreases of expiratory reserve volume (p = 0.03), just after a short session of singing. There was a significant difference on changes of maximal expiratory pressures in the comparison between groups at the end of training. While the control group showed deterioration of maximal expiratory pressure, the singing group exhibited a small improvement (p = 0.05). Both groups showed significant improvements of QoL in within group comparisons. We have concluded that singing classes are a well tolerated activity for selected subjects with COPD. Regular practice of singing may improve QoL, and preserve the maximal expiratory pressure of these patients.


Asunto(s)
Ejercicios Respiratorios , Pulmón/fisiopatología , Musicoterapia , Enfermedad Pulmonar Obstructiva Crónica/terapia , Calidad de Vida , Anciano , Anciano de 80 o más Años , Disnea/etiología , Disnea/fisiopatología , Disnea/psicología , Disnea/terapia , Volumen de Reserva Espiratoria , Femenino , Humanos , Inhalación , Masculino , Persona de Mediana Edad , Presión , Enfermedad Pulmonar Obstructiva Crónica/complicaciones , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Enfermedad Pulmonar Obstructiva Crónica/psicología , Índice de Severidad de la Enfermedad , Espirometría , Encuestas y Cuestionarios , Resultado del Tratamiento
16.
Med Sci Monit ; 14(10): CR524-9, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18830192

RESUMEN

BACKGROUND: Magnesium (Mg) use has the potential to promote bronchodilatation and to improve lung function in obstructive diseases. IV administration of Mg during exacerbations of chronic obstructive pulmonary disease (COPD) has led to improved peak flow. This study aimed to investigate the effects of acute IV Mg loading on respiratory parameters of stable COPD patients. MATERIAL/METHODS: This was a randomized, double-blind, placebo-controlled crossover study. Twenty-two male COPD patients (64+/-6 years old, FEV1: 49+/-20%) received an IV infusion of 2 g of magnesium sulfate or placebo on two distinct occasions. Spirometry and mouth maximal respiratory pressures were obtained before and 45 minutes after the infusions. RESULTS: Mg use led to significant changes in functional respiratory capacity (-0.48 l, 95%CI: -0.96, -0.01), inspiratory capacity (0.21 l, 95%CI: 0.04, 0.37), maximal inspiratory pressure (10 cmH2O, 95%CI: 1.6, 18.4), and maximal expiratory capacity (10.7 cmH2O, 95%CI: 0.20, 21.2). The treatment was also associated with a marginally significant decrease in residual volume (-0.47 L, 95%CI: -0.96, 0.02, p=0.06). CONCLUSIONS: Acute IV Mg loading in stable COPD patients was associated with a reduction in lung hyperinflation and improvement of respiratory muscle strength. The clinical potential for chronic magnesium supplementation in COPD deserves further investigation.


Asunto(s)
Magnesio/uso terapéutico , Enfermedad Pulmonar Obstructiva Crónica , Anciano , Método Doble Ciego , Volumen Espiratorio Forzado/efectos de los fármacos , Humanos , Pulmón/efectos de los fármacos , Pulmón/fisiopatología , Magnesio/sangre , Magnesio/farmacología , Masculino , Persona de Mediana Edad , Placebos , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Pruebas de Función Respiratoria , Mecánica Respiratoria/efectos de los fármacos , Músculos Respiratorios/efectos de los fármacos , Capacidad Pulmonar Total/efectos de los fármacos
17.
Vet. Méx ; 39(3): 247-253, jul.-sep. 2008. ilus
Artículo en Español | LILACS-Express | LILACS | ID: lil-632883

RESUMEN

The hoof is a relatively simple structure, mainly constituted by keratin, a highly sulfated protein, that provides hardness to the hoof and certain elasticity to support the weight and distribute the impact's intensity on the hoof. The hoof needs to have an adequate quality to be able to carry out these functions and that requires a good nutrition based on proteins, vitamins and minerals. Minerals constitute 4% of body weight and they are conformed by macrominerals (calcium, phosphorus, sodium, chloride, potassium, magnesium and sulfur) and microminerals (selenium, iodine, copper and zinc). Zinc participates in hoof formation while inducing keratin production. Its diet deficiency causes problems to the corneous tissue such as: thin and friable hooves, and fissures on the wall. Zn++ must be ingested in chelated form, as zinc methionine, to be adequately absorbed. The diet of seven horses was supplemented with 5.4 g/day/horse of zinc methionine for a period of six months. Samples were obtained from the wall level and transverse cuts were done; before and after the treatment, its morphology and contents of minerals (Mg++, Cl, S, Ca++, Na++, K+, P, Si, Fe++, Cu++,Zn++) were analyzed in the environmental scanning electron microscope equipped with an X ray disperser. It was observed that the morphology presented a better constitution and compactness of the tubular and intratubular horns in the medium stratum, as well as a substantial increment of zinc (32.9%) and sulfur (68.4%), which suggests an increase in keratin and better structure of the hoof.


El casco es una estructura relativamente sencilla, constituida por queratina, proteína bastante sulfatada, que provee al casco de dureza y cierta elasticidad para soportar el peso y distribuir la intensidad del impacto en el casco. Para este fin, se necesita que el casco tenga una calidad adecuada, que requiere de buena nutrición basada en proteínas, vitaminas y minerales. Los minerales constituyen 4% del peso corporal y se conforman en macrominerales (calcio, fósforo, sodio, cloro, potasio, magnesio y azufre) y microminerales (selenio, yodo, cobre y zinc). El zinc participa en la formación del casco al inducir la producción de queratina. Su deficiencia en la dieta causa problemas al tejido córneo, como cascos delgados, friables y fisuras en la pared. Para que el Zn++ sea absorbido adecuadamente, es necesario que sea ingerido en forma quelada como metionina de zinc. La dieta de siete caballos fue complementada con 5.4 g/día/caballo de metionina de zinc por un periodo de seis meses. Se obtuvieron muestras a nivel de la muralla y se realizaron cortes transversales; antes y después del tratamiento, se analizó su morfología y contenido de minerales (Mg++, Cl-, S, Ca++, Na++, K+, P, Si, Fe++, Cu++, Zn++) en el microscopio electrónico de barrido ambiental equipado con dispersor de rayos X. Se observó que la morfología presentaba mejor constitución y compactación de los cuernos tubulares e intratubulares en el estrato medio, así como aumento sustancial de zinc (32.9%) y de azufre (68.4%), lo cual sugiere incremento de queratina y mejor estructuración del casco.

18.
Arch Esp Urol ; 55(5): 560-4, 2002 Jun.
Artículo en Español | MEDLINE | ID: mdl-12174426

RESUMEN

OBJECTIVE: Retrovesical cystic lesions are uncommon, although its incidence is growing due to the use of current diagnostic techniques. Its clinical features are unspecific and can mimic other conditions of the lower urinary tract making the differential diagnosis of this disease entity is difficult. A case of appendiceal mucocele, an unusual retrovesical lesion, is presented. METHODS/RESULTS: A 9 x 14 cm right retrovesical cystic lesion suggestive of a seminal vesicle cyst was detected in a 57-year-old patient with polyalkyuria. The patient was symptomatic, therefore surgical exploration was performed and the lesion was resected. The histological analysis of the surgical specimen demonstrated an appendiceal mucocele with no signs of atypia. The literature is reviewed, with special reference to the diagnostic and therapeutic aspects of this lesion. CONCLUSIONS: We underscore the need to utilize the diagnostic armamentarium (transrectal US, CT, MRI, deferens vesiculography, urethrocystoscopy, colonoscopy, opaque enema, IVP, etc.) to identify retrovesical cystic lesions. Preoperative diagnosis is necessary in appendiceal mucocele to avoid rupture during the surgical procedure and prevent peritoneal pseudomyxoma. Occasionally, however, the definitive diagnosis of these retrovesical lesions can be made only by punction biopsy or surgical exploration.


Asunto(s)
Apéndice , Enfermedades del Ciego/diagnóstico , Mucocele/diagnóstico , Apendicectomía , Enfermedades del Ciego/complicaciones , Enfermedades del Ciego/cirugía , Diagnóstico Diferencial , Humanos , Masculino , Persona de Mediana Edad , Mucocele/complicaciones , Mucocele/cirugía , Hiperplasia Prostática/complicaciones
19.
Arch. esp. urol. (Ed. impr.) ; 55(5): 560-564, jun. 2002.
Artículo en Es | IBECS | ID: ibc-13268

RESUMEN

OBJETIVO: Las lesiones quísticas retrovesicales son una realidad clínica infrecuente de incidencia creciente debido a las modernas técnicas diagnósticas existentes. No obstante, su inespecificidad clínica, pudiendo simular cualquier proceso patológico del tracto urinario inferior, y su complejo diagnóstico diferencial hacen de esta entidad un tema de interés.MÉTODOS Y RESULTADOS: Presentamos un paciente de 57 años de edad con clínica de polaquiuria al que se le diagnostica con métodos de imagen una lesión quística de 9 x 14 cm en situación retrovesical derecha sugestiva de quiste de vesícula seminal. Dado el carácter sintomático de la lesión, se practica exploración quirúrgica y exéresis de la citada lesión resultando en el estudio histológico posterior un mucocele apendicular sin signos de atipia. Revisamos aspectos diagnósticos y terapéuticos en la literatura.CONCLUSIONES: Destacamos la necesidad del empleo del arsenal diagnóstico necesario (ecografía transrectal, T.A.C., R.N.M., deferentovesiculografía, uretrocistoscopia, colonoscopia, enema opaco, urografía intravenosa,...) en aras a filiar las características de las lesiones quísticas retrovesicales. El diagnóstico preoperatorio es necesario en el mucocele apendicular con objeto de evitar su ruptura durante la cirugía y prevenir el pseudomixoma peritoneal.No obstante, en ocasiones sólo la punción biopsia o la exploración quirúrgica permiten establecer el diagnóstico definitivo de estas lesiones retrovesicales (AU)


Asunto(s)
Persona de Mediana Edad , Masculino , Humanos , Apéndice , Mucocele , Hiperplasia Prostática , Apendicectomía , Enfermedades del Ciego , Diagnóstico Diferencial
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA